Neuroprotection by urate on 6‐OHDA‐lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway

作者: Li Gong , Qi-Lin Zhang , Ning Zhang , Wen-Yan Hua , Yi-Xian Huang

DOI: 10.1111/JNC.12038

关键词: NeuroprotectionProtein kinase BNigrostriatal pathwayStriatumBiochemistryPI3K/AKT/mTOR pathwayDopamineDopaminergicNeurotoxicityInternal medicineChemistryEndocrinology

摘要: Higher plasma urate level is reported to be associated with a reduced risk and slower progression of Parkinson's disease (PD). In this study, we explored the effects on dopaminergic neurons in nigrostriatal pathway 6-hydroxydopamine (6-OHDA) unilaterally lesioned rats. Uric acid (UA), when given twice daily at 200 mg/kg intraperitoneally for 10 consecutive days, elevated (the anionic form UA) striatum by 55% 36.8%, respectively, as compared vehicle group. This regimen UA was found ameliorate behavioral deficits, neuron loss well dopamine depletion system. Moreover, administration capable increasing glutathione superoxide dismutase activity while decreasing malondialdehyde accumulation striatum. addition, phosphorylation both protein kinase B (Akt) glycogen synthase 3 beta (GSK3β) striata 6-OHDA-lesioned rats dramatically sham-operated reduction attenuated Parkinsonian receiving treatment. Similarly, vitro findings showed that alleviated decrease Akt activation increase GSK3β caused 6-OHDA. Furthermore, neuroprotection its regulation Ser9 abolished presence PI3K inhibitor. Therefore, our demonstrated able protect rat against neurotoxicity 6-OHDA, beneficial may related Akt/GSK3β signaling.

参考文章(28)
Nobutaka Hattori, Tomonori Kobayashi, Satoe Shimoda-Matsubayashi, Hiroto Matsumine, Tomoyoshi Kondo, Yoshikuni Mizuno, Hiroyo Yoshino, Shin-Ichiro Ikebe, Mitochondrial dysfunction in Parkinson's disease. Annals of Neurology. ,vol. 44, ,(1998) , 10.1002/ANA.410440715
K J A Davies, A Sevanian, S F Muakkassah-Kelly, P Hochstein, Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochemical Journal. ,vol. 235, pp. 747- 754 ,(1986) , 10.1042/BJ2350747
Peter Jenner, C. Warren Olanow, Understanding cell death in Parkinson's disease Annals of Neurology. ,vol. 44, ,(1998) , 10.1002/ANA.410440712
Lih-Wuu Chang, Pie-Yau Chien, Ching-Ting Lee, Measurement of absolute displacement by a double-modulation technique based on a Michelson interferometer. Applied Optics. ,vol. 38, pp. 2843- 2847 ,(1999) , 10.1364/AO.38.002843
D. C. Hooper, O. Bagasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J. L. Farber, T. Akaike, H. Maeda, H. Koprowski, Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 2528- 2533 ,(1997) , 10.1073/PNAS.94.6.2528
Tua Annanmaki, Antti Muuronen, Kari Murros, Low plasma uric acid level in Parkinson's disease. Movement Disorders. ,vol. 22, pp. 1133- 1137 ,(2007) , 10.1002/MDS.21502
John K. Maesaka, Gisele Wolf-Klein, Joanne M. Piccione, Chan M. Ma, Hypouricemia, Abnormal Renal Tubular Urate Transport, and Plasma Natriuretic Factor(s) in Patients with Alzheimer's Disease Journal of the American Geriatrics Society. ,vol. 41, pp. 501- 506 ,(1993) , 10.1111/J.1532-5415.1993.TB01885.X
Yangzhou Du, Christopher P. Chen, Chia-Yi Tseng, Yuval Eisenberg, Bonnie L. Firestein, Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia. ,vol. 55, pp. 463- 472 ,(2007) , 10.1002/GLIA.20472
Bernhard F. Becker, Towards the physiological function of uric acid Free Radical Biology and Medicine. ,vol. 14, pp. 615- 631 ,(1993) , 10.1016/0891-5849(93)90143-I